| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
2,431 |
2,077 |
$1.50M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,001 |
9,867 |
$1.31M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,406 |
5,500 |
$979K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,353 |
6,732 |
$953K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
543 |
474 |
$422K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
850 |
795 |
$372K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,688 |
4,313 |
$329K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,410 |
1,022 |
$202K |
| 71046 |
Radiologic examination, chest; 2 views |
2,427 |
1,936 |
$100K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
484 |
402 |
$99K |
| 80053 |
Comprehensive metabolic panel |
7,843 |
6,614 |
$91K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,656 |
832 |
$60K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
475 |
424 |
$57K |
| 86328 |
|
1,464 |
1,292 |
$54K |
| 95065 |
|
2,101 |
1,818 |
$45K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
802 |
589 |
$40K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,114 |
2,589 |
$40K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,631 |
2,282 |
$39K |
| 71045 |
Radiologic examination, chest; single view |
3,142 |
2,279 |
$28K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,321 |
2,013 |
$26K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
475 |
409 |
$16K |
| 97161 |
|
141 |
128 |
$14K |
| 73630 |
|
270 |
192 |
$12K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,554 |
1,359 |
$11K |
| 72110 |
|
64 |
54 |
$9K |
| 80320 |
|
995 |
770 |
$8K |
| 73562 |
|
119 |
79 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,794 |
1,629 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,715 |
3,230 |
$7K |
| G0378 |
Hospital observation service, per hour |
38 |
24 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,576 |
7,247 |
$6K |
| 73030 |
|
125 |
99 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,720 |
1,612 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,825 |
2,219 |
$4K |
| 73610 |
|
43 |
37 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
550 |
522 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
208 |
179 |
$3K |
| 80306 |
|
1,292 |
1,118 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
94 |
77 |
$3K |
| 84484 |
|
1,736 |
1,474 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
12 |
12 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,453 |
1,314 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,439 |
1,273 |
$2K |
| 73130 |
|
28 |
27 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
214 |
200 |
$2K |
| 94664 |
|
652 |
573 |
$2K |
| 96376 |
|
476 |
377 |
$1K |
| 73110 |
|
59 |
50 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
11,618 |
9,544 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
120 |
104 |
$908.42 |
| 83880 |
|
140 |
121 |
$760.38 |
| 83690 |
|
1,885 |
1,644 |
$717.26 |
| 84703 |
|
1,431 |
1,298 |
$695.15 |
| 97032 |
|
1,228 |
369 |
$572.61 |
| 80061 |
Lipid panel |
658 |
621 |
$523.35 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
542 |
511 |
$479.97 |
| 87081 |
|
262 |
247 |
$464.08 |
| 81002 |
|
3,118 |
2,781 |
$423.05 |
| 85610 |
|
1,164 |
1,018 |
$357.01 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,464 |
2,941 |
$341.87 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
63 |
61 |
$323.48 |
| 87899 |
|
550 |
522 |
$310.19 |
| 81000 |
|
1,553 |
1,363 |
$301.96 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
281 |
268 |
$277.73 |
| 85379 |
|
429 |
373 |
$270.88 |
| 83605 |
|
365 |
318 |
$214.55 |
| 85730 |
|
453 |
399 |
$197.89 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
186 |
158 |
$196.37 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,247 |
1,986 |
$191.27 |
| 83735 |
|
574 |
508 |
$187.79 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,670 |
1,485 |
$170.34 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
973 |
845 |
$169.44 |
| 85027 |
|
228 |
194 |
$112.61 |
| 85007 |
|
233 |
198 |
$86.89 |
| 82550 |
|
68 |
64 |
$57.39 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
571 |
528 |
$56.46 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
181 |
152 |
$48.73 |
| 94760 |
|
31 |
26 |
$40.78 |
| 84439 |
|
99 |
94 |
$25.66 |
| 87280 |
|
98 |
97 |
$21.80 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
61 |
50 |
$21.26 |
| J2060 |
Injection, lorazepam, 2 mg |
366 |
302 |
$16.79 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
26 |
25 |
$7.36 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
30 |
27 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
48 |
41 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
45 |
37 |
$0.00 |
| 93000 |
|
65 |
61 |
$0.00 |
| 84480 |
|
16 |
14 |
$0.00 |
| 87040 |
|
17 |
12 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
380 |
354 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12 |
12 |
$0.00 |
| 77003 |
|
13 |
13 |
$0.00 |
| 80305 |
|
16 |
13 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
22 |
21 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
15 |
$0.00 |